You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunotoxicity

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Autoimmunity After Checkpoint Blockade

Recruiting
  • Autoimmunity
  • +3 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania - Abramson Cancer Center
    Nov 29, 2021

    Skin Toxicity, Immunotoxicity Trial in Hasselt (Hydrating emollient + body lotion for immunotherapy-related side effects)

    Recruiting
    • Skin Toxicity
    • Immunotoxicity
    • Hydrating emollient + body lotion for immunotherapy-related side effects
    • Hasselt, Limburg, Belgium
      Jessa Ziekenhuis VZW
    Dec 2, 2021

    Immunotoxicity, Anesthesia, Inert Gas Narcosis Trial in Mannheim (High dose propofol, fentanyl and sevoflurane, Low dose

    Completed
    • Immunotoxicity
    • +2 more
    • High dose propofol, fentanyl and sevoflurane
    • Low dose propofol, fentanyl and sevoflurane
    • Mannheim, Germany
      University Medicine of Mannheim, Dept. Anesthesiology and Critic
    May 17, 2022

    SARS-CoV-2, Safety, Immunotoxicity Trial in Wuhan (one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006), Cellular Immunity,

    Not yet recruiting
    • SARS-CoV-2
    • +2 more
    • one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006)
    • +3 more
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Aug 9, 2022

    SARS-CoV-2, Prevention Trial in Chongqing (A8G6 SARS-CoV-2 Neutralization Antibody combination nasal spray, A8G6 SARS-CoV-2

    Recruiting
    • SARS-CoV-2
    • Prevention
    • A8G6 SARS-CoV-2 Neutralization Antibody combination nasal spray
    • A8G6 SARS-CoV-2 Neutralization Antibody nasal excipient
    • Chongqing, Chongqing, China
      The Second Affiliated Hospital of Chongqing Medical University
    Nov 9, 2023

    SARS-CoV-2, Prevention Trial in Chongqing (MY-586 SARS-CoV-2 Neutralizing Antibody nasal spray, Placebo Comparator: MY-586

    Recruiting
    • SARS-CoV-2
    • Prevention
    • MY-586 SARS-CoV-2 Neutralizing Antibody nasal spray
    • Placebo Comparator: MY-586 SARS-CoV-2 Neutralization Antibody nasal excipient
    • Chongqing, Chongqing, China
      The Second Affiliated Hospital of Chongqing Medical University
    Aug 2, 2023

    Cytokine Release Syndrome Trial (CTO1681 10 µg, CTO1681 20 µg, CTO1681 30 µg)

    Not yet recruiting
    • Cytokine Release Syndrome
    • CTO1681 10 μg
    • +2 more
    • (no location specified)
    Jun 6, 2023

    Peanut Allergy Trial (VLP Peanut, Placebo)

    Not yet recruiting
    • Peanut Allergy
    • VLP Peanut
    • Placebo
    • (no location specified)
    Jul 25, 2022

    Associated With Colorectal Cancer

    Not yet recruiting
    • Colorectal Neoplasms
    • Assessment of smoking ,heavy metal, organophosphorus exposure and d) Mutational analysis of the KRAS and BRAF genes:
    • (no location specified)
    Dec 18, 2021

    Periodontitis Chronic Generalized Severe Trial in Beirut (2.5% flurbiprofen, 98% aloe vera, Placebo)

    Completed
    • Periodontitis Chronic Generalized Severe
    • 2.5% flurbiprofen
    • +2 more
    • Beirut, Lebanon
      Beirut Arab University
    Sep 11, 2023

    Associated With Occupational Exposure to Trichloroethylene

    Completed
    • Industrial Hygiene
    • +2 more
      • Guangzhou, China
        Guangdong National Poison Control Center (NPCC)
      Oct 30, 2020

      Exposure to Environmental Pollution Trial in Haifa, Tel Aviv, Zerifin

      Active, not recruiting
      • Exposure to Environmental Pollution
        • Haifa, Israel
        • +2 more
        Apr 4, 2022

        Developmental Impacts of Microplastics Exposure in Early Life

        Recruiting
        • Infant Development
        • +2 more
        • Observational only
        • Boulder, Colorado
          Clinical Translational Research Center CU Boulder
        Oct 24, 2023

        Pregnancy, Arsenic and Immune Response

        Unknown status
        • Arsenic--Toxicology
        • +4 more
        • Seasonal influenza vaccine - VAXIGRIP TETRA influenza vaccine (quadrivalent, split virion, inactivated)
        • Gaibandha, Bangladesh
          JiVitA Maternal and Child Health and Nutrition Research Program
        May 2, 2019

        Chronic Lymphocytic Leukemia Trial (Dermal Chelation, Nutritional Therapy)

        Unknown status
        • Chronic Lymphocytic Leukemia
        • Dermal Chelation
        • Nutritional Therapy
        • (no location specified)
        Apr 4, 2018

        Arsenic Poisoning Trial in Dhaka (high-selenium lentils, Low-Se lentils)

        Completed
        • Arsenic Poisoning
        • high-selenium lentils
        • Low-Se lentils
        • Dhaka, Bangladesh
          Field Office, International Centre for Diarrhoeal Disease Resear
        Mar 29, 2017

        HIV Prevention, HIV Trial in Los Angeles, Pittsburgh (Tenofovir, HEC Placebo, Open label tenofovir tablet)

        Completed
        • HIV Prevention
        • HIV Infections
        • Los Angeles, California
        • +1 more
        Aug 27, 2015

        HIV Prevention Trial in Los Angeles, Pittsburgh (Rectal formulation (RF) of tenofovir 1% gel, Vaginal formulations (original VF

        Completed
        • HIV Prevention
        • Rectal formulation (RF) of tenofovir 1% gel
        • +2 more
        • Los Angeles, California
        • +1 more
        Nov 6, 2013